# Neurodome

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/neurodome

- Industry: Medical Devices & Equipment
- Headquarters: Xi'an, China
- Website: www.neurodome-med.com
- Total disclosed funding: $15M
- Latest round: Series A (Mar 12, 2026)
- Investors on record: 8

## About

Based in Xi'an, China, and founded in 2019, Xi'an NeuroDome Medical Technology Co., Ltd., trading under the name Neurodome, is a company focusing on the field of non-invasive deep brain neural regulation. It has been awarded the Excellent Award in the Innovation and Entrepreneurship Competition of Zhihui Sugaoxin. The company also has a branch in Suzhou, China. The company's co-founder, chairman of the board, and CEO, Long Li, graduated from Xi'an Jiaotong University. In March 2026, the firm raised approximately CNY 100 million in series A+ funding led by Mingxi Capital.

The company focuses on providing treatment solutions for patients with central peripheral nervous system diseases and chronic mental disorders. The non-invasive deep brain neural regulation product TIs EMO-1000/TIs CAP contains ultra-high precision stimulus control function.

Neurodome generates revenue by developing non-invasive deep brain nerve regulation technology and products.

The company plans to use the series A+ funding to accelerate product iteration, advance clinical registration, expand its commercial footprint, and explore innovative technologies.

## Funding rounds

- Series A, Mar 12, 2026, $15M — Oriza Holdings, Hubei Science Technology Investment Group, Shunwei Capital, Kexun Ruijin Capital, Huafang Capital, Mingxi Capital
- Series A, Feb 24, 2025 — Kexun Ruijin Capital, Huafang Capital, Tianjin Binhai Zhengxin Asset Management
- Angel, Jan 3, 2023 — Shunwei Capital, Frees Fund

## Investors

- Shunwei Capital (https://capitalatlas.ai/funds/shunwei-capital) — Angel, Series A
- Frees Fund (https://capitalatlas.ai/funds/frees-fund) — Angel
- Kexun Ruijin Capital (https://capitalatlas.ai/funds/kexun-ruijin-capital) — Series A
- Huafang Capital (https://capitalatlas.ai/funds/huafang-capital) — Series A
- Tianjin Binhai Zhengxin Asset Management — Series A
- Oriza Holdings (https://capitalatlas.ai/funds/oriza-holdings) — Series A
- Hubei Science Technology Investment Group — Series A
- Mingxi Capital (https://capitalatlas.ai/funds/mingxi-capital) — Series A